What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Vall d'Hebron identifies a new therapeutic target for an aggressive childhood cancer affecting the muscles The research team has shown that inhibiting the TRIB3 protein slows the growth of rhabdomyosarcoma and improves survival in animal models. Activities Vall d’Hebron Ventures Summit 16:30h Benvinguda institucional 16:45h Presentacions companyies (1a part): Imidomics (Sara Marsal, CMO), Bsure M News The PHASE IV AI project organizes a session to evaluate the impact of artificial intelligence on lung cancer care The event, organized by Vall d'Hebron and Eurecat, has brought together health professionals and researchers in clinically applied AI to improve the medical care of patients. Activities Defensa de Tesi 'Avanç en les cures infermeres a les persones amb malaltia inflamatòria intestinal' Doctoranda: Ester Navarro Correal, grup de Recerca Multidisciplinari d'infermeria del Vall d'Hebron Institut de Recerca (VHIR) Directores: Dra. Laia Selva i Dra. Anna Espart Tutora: Dra. Anna Espart Enllaç Activities Vall d'Hebron Talks by VHIR 'iPSC- and CRISPR-based 3D brain tissue models recapitulate key features of neurodegenerative and neurovascular diseases' Speaker: Dr. Dominik Paquet, Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany Brain research heavily depends on models recapitulating key aspects of human brain physiology and disease pathology. Human iPSCs have great potential to comple Activities Vall d'Hebron Talks by VHIR 'Descripció funcionament procés d'Innovació VHIR' Presentació dels nous criteris multidimensionals que permeten fer un millor acompanyament als projectes d'Innovació segons el nivell de maduresa i les necessitats en cada etapa del procés. Ponents: Activities Actualizaciones y controversias en la monitorización de la PIC y de la presión de perfusión cerebral en el paciente neurocrítico Más información: https://aula.vallhebron.com/aula/?go=info_cursos&curso=660 Para cualquier otra información Activities Jornada 'Dia Internacional de la Immunologia' 09:00-9:30 Inauguració de la jornada a càrrec de la Dra. María José Abadías, Directora Assistencial de l'Hospital Universitari Vall d'Hebron i Dr. Manuel Hernández, Cap del Servei d'Immunologia de l'Hospital Universitari Vall d'Hebron Activities Jornada 'Optimizing transplantation of congenital errors of immunity' 14.30-14.45. Welcome and introduction: Anna Millan (BST) + Carlota Villar (BCN-PIDFoundation) + Pere Soler Palacin (VH) 14.45-15.35. Is the donor a limiting factor? Chairs: Sergi Querol (BST) + Cristina Diaz de Heredia (VH) (2 x 20 min and 10 min Q&A) • CD45RO+ infusion op News Haematopoietic stem cell transplantation from an unrelated donor works as a curative therapy for children with non-oncological blood disorders Vall d'Hebron presents positive results from two studies in transfusion-dependent thalassaemia and severe bone marrow aplasia at the EBMT Annual Meeting on haematopoietic stem cell transplantation. Activities Curso de introducción a la metodología estadística en investigación en salud Más Información: https://aula.vallhebron.com/aula/?go=info_cursos&curso=612 Aula Vall d'Hebron News A potentially modifying gene is identified as a cause of primary ciliary dyskinesia in a patient with retinitis pigmentosa The study, in which Vall d'Hebron participates, helps to understand the variability among patients with retinitis pigmentosa. Activities Defensa de Tesi 'Registre de factors pronòstics de la miocardiopatia aritmogènica de predomini esquerre' Doctorand; Javier Limeres Freire, grup de Recerca de Malalties Cardiovasculars (VHIR) Director i Tutor: Dr. José Fernando Rodríguez Palomares Activities Defensa de Tesi 'Aplicació clínica de l'ecografia pulmonar a l'estudi de la pneumònia per SARS-CoV-2 i les seves seqüeles' Doctorand: David V. Clofent Alarcón, Pneumologia (VHIR) -Directors: Dra. Eva Polverino i Dr. Mario Culebras -Tutor: Dr. Jaume Ferrer News Vall d'Hebron organizes the 1st International Health Communication Congress For two days, communication professionals from health and research institutions, experts in the field of health communication and specialized journalists from around the world will meet to debate the key issues of the present and the future. News A clinical trial has demonstrated the efficacy of a shorter treatment for Chagas disease La nova pauta té la mateixa eficàcia que l’estàndard, però només una quarta part de la durada, el que redueix el percentatge d’abandonaments i efectes secundaris. News A project by the Hipofam association obtains 21,000 € from the Inocente Inocente foundation for research into an ultra-rare kidney disease at Vall d'Hebron The research will perform a functional analysis of phenotype-modifying genetic variants in patients affected by familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (HFHNC). News A new therapeutic strategy improves the control of motor symptoms in patients with Parkinson's disease Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy. News Vall d'Hebron initiates a citizen science project with adolescents and Parkinson's patients This initiative is part of a pioneering study that seeks to assess how the relationship between different age groups can influence the quality of life and mental health of patients. Activities Vall d'Hebron Talks by VHIR 'Yet another transcriptomic-based signature for cancer prognosis' Speaker: Dr. Jose Antonio Seoane Fernández, coordinates the Cancer Computational Biology group at VHIO. Originally trained as a computer scientist, he transitioned to cancer genomics and epigenetics during his postdoctoral research at the Christina Curtis lab at Stanford University. In 2021 Pagination First page « Previous page ‹ … Page 13 Page 14 Current page 15 Page 16 Page 17 … Next page › Last page »
